Business Context and Reporting Period
Lifemd, Inc. (LFMD) is a direct-to-patient telehealth company operating two primary segments: Telehealth (including brands like LifeMD Primary Care, RexMD, ShapiroMD, and Cleared) and WorkSimpli (a SaaS platform for document services). This Form 10-Q covers the quarterly period ended September 30, 2024. The company operates as an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Total Revenue | $53.4 million | $38.6 million | $148.2 million | $107.7 million |
| Gross Profit | $48.4 million | $33.8 million | $133.6 million | $94.1 million |
| Gross Margin | 90.6% | 87.6% | 90.1% | 87.4% |
| Operating Loss | $(4.7) million | $(4.6) million | $(17.2) million | $(12.3) million |
| Net Loss (Common Stockholders) | $(5.9) million | $(6.9) million | $(21.1) million | $(19.2) million |
| Cash and Equivalents | $37.6 million | $15.3 million (Q3 2023) | $37.6 million (Sep 30, 2024) | $3.9 million (Dec 31, 2023) |
| Operating Cash Flow (YTD) | $15.9 million | $3.1 million | $15.9 million | $3.1 million |
| Long-Term Debt (Net) | $13.0 million | $17.9 million | $13.0 million | $17.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 38% year-over-year (YTD) and 38% quarter-over-quarter. Telehealth revenue grew 62% YTD, driven primarily by LifeMD Primary Care and the Medifast collaboration. WorkSimpli revenue declined slightly (3% YTD).
- Expense Increases: Operating expenses rose 42% YTD to $150.7 million. Selling and marketing expenses increased $21.1 million (38%) due to aggressive customer acquisition for primary care. General and administrative expenses increased $16.6 million, largely due to higher compensation costs and legal fees.
- Profitability: While gross margins improved to 90.1% YTD (from 87.4%), the company reported a net loss attributable to common stockholders of $21.1 million for the nine months ended September 30, 2024, compared to $19.2 million in the prior year period.
- Liquidity: Cash on hand increased to $37.6 million as of September 30, 2024, up from $33.1 million at year-end 2023. Working capital turned negative to $(10.3) million due to a significant increase in current liabilities (deferred revenue and accounts payable).
Guidance, Outlook, and Risks
- Liquidity Outlook: Management expects to maintain positive operating cash flows for the next 12 months. The company cites $37.6 million in cash and $53.3 million available under its At-The-Market (ATM) sales agreement as key indicators of sufficient liquidity.
- Strategic Initiatives: The company continues to expand its GLP-1 Weight Management program, which had over 71,000 subscribers as of September 30, 2024. In September 2024, they launched an alternative non-GLP-1 weight management plan.
- Debt Covenants: The company is in compliance with its Avenue Credit Facility covenants, which require maintaining at least $5 million in unrestricted cash and a trailing six-month cash flow of at least $2 million.
- Internal Controls: The company disclosed material weaknesses in internal control over financial reporting related to IT program change management, user access, and business process controls. Management is actively remediating these issues.
- Legal and Regulatory: The company is facing a putative class action lawsuit regarding unauthorized disclosure of information (Marden v. LifeMD, Inc.) and an IRS notice of deficiency regarding a $1.9 million tax deficiency for the 2019 tax year.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of remediation plans for the disclosed material weaknesses in IT and financial reporting controls.
- Debt Covenants: Monitor compliance with the Avenue Facility covenants, specifically the $5 million unrestricted cash requirement and cash flow thresholds.
- Legal Proceedings: Track the status of the Marden class action lawsuit and the IRS tax dispute, as outcomes could result in significant liabilities.
- Customer Acquisition Costs: Assess the sustainability of the 38% increase in selling and marketing expenses relative to the growth in recurring subscription revenue.
- Preferred Stock Dividends: Note the quarterly cash outflow of approximately $0.78 million for Series A Preferred Stock dividends, which reduces net income available to common stockholders.